| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10072-017-2841-9 |
| P698 | PubMed publication ID | 28181066 |
| P2093 | author name string | Na Li | |
| Xudong Pan | |||
| Jingli Zhang | |||
| Aijun Ma | |||
| Juanjuan Ma | |||
| Anmu Xie | |||
| Shaonan Yang | |||
| P2860 | cites work | MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function | Q39545068 |
| miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche | Q42243673 | ||
| Plasma-based circulating MicroRNA biomarkers for Parkinson's disease | Q44075654 | ||
| Patterns of motor and non-motor features in Parkinson's disease. | Q48409698 | ||
| A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia | Q48462604 | ||
| Gene expression networks in COPD: microRNA and mRNA regulation. | Q54347289 | ||
| Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging | Q57417852 | ||
| MicroRNAs in Parkinson's disease | Q83371481 | ||
| Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls | Q86512971 | ||
| Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease | Q86847853 | ||
| Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression | Q24293587 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations | Q28282629 | ||
| A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 | ||
| Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
| Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
| Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. | Q33873827 | ||
| MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects | Q34200641 | ||
| Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease | Q34305931 | ||
| Systems biology of the autophagy-lysosomal pathway | Q35079473 | ||
| miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling. | Q35100268 | ||
| High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model | Q35771016 | ||
| Pathogenetic and therapeutic applications of microRNAs in major depressive disorder | Q35956471 | ||
| Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease | Q36278180 | ||
| MicroRNA functions in animal development and human disease | Q36285673 | ||
| Expanding insights of mitochondrial dysfunction in Parkinson's disease. | Q36404133 | ||
| MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. | Q36525872 | ||
| Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration | Q37237452 | ||
| Fine-tuning the brain: MicroRNAs | Q37580299 | ||
| Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
| MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim. | Q38874732 | ||
| P433 | issue | 5 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 761-767 | |
| P577 | publication date | 2017-02-08 | |
| P1433 | published in | Neurological Sciences | Q15763262 |
| P1476 | title | Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression | |
| P478 | volume | 38 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q48170877 | Association of variants in microRNA with Parkinson's disease in Chinese Han population. |
| Q94560701 | Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease |
| Q58762806 | Circulating miRNAs as Diagnostic Biomarkers for Parkinson's Disease |
| Q89702449 | Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker |
| Q48324230 | MiR-137 inhibited inflammatory response and apoptosis after spinal cord injury via targeting of MK2. |
| Q38765914 | Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease |
| Q38431496 | Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease |
| Q48098159 | The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5. |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q92618796 | miR-423-5p inhibits the proliferation and metastasis of glioblastoma cells by targeting phospholipase C beta 1 |
Search more.